Entero Therapeutics, Inc. (ENTO)
NASDAQ: ENTO · Real-Time Price · USD
2.275
+0.125 (5.81%)
Aug 29, 2025, 4:00 PM - Market closed
Entero Therapeutics Market Cap
Entero Therapeutics has a market cap or net worth of $3.61 million as of August 29, 2025. Its market cap has increased by 416.29% in one year.
Market Cap
3.61M
Enterprise Value
4.45M
1-Year Change
416.29%
Ranking
Category
Stock Price
2.28
Market Cap Chart
Since October 11, 2016, Entero Therapeutics's market cap has decreased from $48.90M to $3.61M, a decrease of -92.61%. That is a compound annual growth rate of -25.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 29, 2025 | 3.60M | 20.00% |
| Dec 31, 2024 | 3.00M | 7.14% |
| Dec 29, 2023 | 2.80M | -45.10% |
| Dec 30, 2022 | 5.10M | -71.67% |
| Dec 31, 2021 | 18.00M | -38.98% |
| Dec 31, 2020 | 29.50M | 8.06% |
| Dec 31, 2019 | 27.30M | 33.82% |
| Dec 31, 2018 | 20.40M | -51.66% |
| Dec 29, 2017 | 42.20M | -7.05% |
| Dec 30, 2016 | 45.40M | -7.16% |
| Oct 11, 2016 | 48.90M | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 657.66B |
| Johnson & Johnson | 426.69B |
| AbbVie | 371.68B |
| UnitedHealth Group | 280.64B |
| Novo Nordisk | 254.41B |
| AstraZeneca | 248.96B |
| Novartis AG | 245.38B |
| Abbott Laboratories | 230.89B |